肝硬化合并门静脉血栓病因研究进展
Research Progress on Etiology of Cirrhosis with Portal Vein Thrombosis
DOI: 10.12677/ACM.2020.103030, PDF,   
作者: 刘 倩, 韩 文：延安大学附属医院，陕西 延安
关键词: 肝硬化；门静脉血栓；病因研究；综述；Liver Cirrhosis； Portal Vein Thrombosis； Etiology Studies； Progress
摘要: 门静脉血栓(Portal vein thrombosis, PVT)是肝硬化自然进程中很常见的并发症，其发病率与肝硬化程度相关。随着诊断手段的发展及临床医生意识的提高，PVT更多被人熟知。本文将就肝硬化合并门静脉血栓病因相关研究进展作一综述，旨在进一步加深临床医生对PVT的认识，有助于筛选出可用于临床检测的有效指标，更好地进行PVT的预防及诊治。
Abstract: Portal vein thrombosis (PVT) as a very common complication in the natural course of cirrhosis, its incidence is related to the degree of cirrhosis. With the development of diagnostic methods and increasing awareness of clinicians, PVT is better known. This article will review the research pro-gress on the etiology of liver cirrhosis with portal vein thrombosis. The purpose is to further deepen the clinician’s understanding of PVT and help to screen out effective indicators that can be used for clinical detection to better prevent and diagnose PVT.
文章引用：刘倩, 韩文. 肝硬化合并门静脉血栓病因研究进展[J]. 临床医学进展, 2020, 10(3): 185-190. https://doi.org/10.12677/ACM.2020.103030

参考文献

[1] Sheen, C.L., Lamparelli, H., Milne, A., Green, I. and Ramage, J.K. (2000) Clinical Features, Diagnosis and Outcome of Acute Portal Vein Thrombosis. QJM, 93, 531-534. [Google Scholar] [CrossRef] [PubMed]
[2] Condat, B., Pessione, F., Helene Denninger, M., Hillaire, S. and Valla, D. (2000) Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy. Hepatology, 32, 466-470. [Google Scholar] [CrossRef] [PubMed]
[3] Francoz, C., Belghiti, J., Vilgrain, V., et al. (2005) Splanchnic Vein Thrombosis in Candidates for Liver Transplantation: Usefulness of Screening and Anticoagulation. Gut, 54, 691-697. [Google Scholar] [CrossRef] [PubMed]
[4] Okuda, K., Ohnishi, K., Kimura, K., et al. (1985) Incidence of Portal Vein Thrombosis in Liver Cirrhosis. An Angiographic Study in 708 Patients. Gastroenterology, 89, 279-286. [Google Scholar] [CrossRef] [PubMed]
[5] Stine, J.G., Argo, C.K., Pelletier, S.J., Maluf, D.G., Caldwell, S.H. and Northup, P.G. (2017) Advanced Non-Alcoholic Steatohepatitis Cirrhosis: A High-Risk Population for Pre-Liver Transplant Portal Vein Thrombosis. World Journal of Hepatology, 9, 139-146. [Google Scholar] [CrossRef] [PubMed]
[6] Stine, J.G., Shah, N.L., Argo, C.K., Pelletier, S.J., Caldwell, S.H. and Northup, P.G. (2015) Increased Risk of Portal Vein Thrombosis in Patients with Cirrhosis Due to Nonalcoholic Steatohepatitis. Liver Transplantation, 21, 1016-1021. [Google Scholar] [CrossRef] [PubMed]
[7] Ruiz, P., Sastre, L., Crespo, G., et al. (2017) Increased Risk of Portal Vein Thrombosis in Patients with Autoimmune Hepatitis on the Liver Transplantation Waiting List. Clinical Transplantation, 31, e13001. [Google Scholar] [CrossRef] [PubMed]
[8] Balfour, G.W. and Stewart, T.G. (1869) Case of Enlarged Spleen Compli-cated with Ascites, Both Depending upon Varicose Dilatation and Thrombosis of the Portal Vein. Edinburgh Medical Journal, 14, 589-598.
[9] Chawla, Y.K. and Bodh, V. (2015) Portal Vein Thrombosis. Journal of Clinical and Ex-perimental Hepatology, 5, 22-40. [Google Scholar] [CrossRef] [PubMed]
[10] Zocco, M.A., Di Stasio, E., De Cristofaro, R., Novi, M., Ainora, M.E., Ponziani, F., Riccardi, L., Lancellotti, S., Santoliquido, A., Flore, R., Pompili, M., Rapaccini, G.L., Tondi, P., Gasbarrini, G.B., Landolfi, R. and Gasbarrini, A. (2009) Thrombotic Risk Factors in Patients with Liver Cirrhosis: Correlation with MELD Scoring System and Portal Vein Thrombosis Development. Journal of Hepatology, 51, 682-689. [Google Scholar] [CrossRef] [PubMed]
[11] Stine, J.G., Wang, J., Shah, P.M., Argo, C.K., Intagliata, N., Uflacker, A., Caldwell, S.H. and Northup, P.G. (2018) Decreased Portal Vein Velocity Is Predictive of the Development of Portal Vein Thrombosis: A Matched Case-Control Study. Liver International, 38, 94-101. [Google Scholar] [CrossRef] [PubMed]
[12] Maruyama, H., Okugawa, H., Takahashi, M. and Yokosuka, O. (2013) De Novo Portal Vein Thrombosis in Virus-Related Cirrhosis: Predictive Factors and Long-Term Outcomes. American Journal of Gastroenterology, 108, 568-574. [Google Scholar] [CrossRef] [PubMed]
[13] Nery, F., Correia, S., Macedo, C., Gandara, J., Lopes, V., Valadares, D., Ferreira, S., Oliveira, J., Gomes, M.T., Lucas, R., Rautou, P.E., Miranda, H.P. and Valla, D. (2019) Nonselective Beta-Blockers and the Risk of Portal Vein Thrombosis Inpatients with Cirrhosis: Results of a Prospective Longitudinal Study. Alimentary Pharmacology & Therapeutics, 49, 582-588. [Google Scholar] [CrossRef] [PubMed]
[14] Zampino, R., Lebano, R., Coppola, N., Macera, M., Grandone, A., Rinaldi, L., De Sio, I., Tufano, A., Stornaiuolo, G., Adinolfi, L.E., Durante-Mangoni, E., Battista, G.G. and Niglio, A. (2018) The Use of Nonselective Beta Blockers Is a Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients. Saudi Journal of Gastroenterology, 24, 25-29. [Google Scholar] [CrossRef] 
[15] Violi, F., Corazza, G.R., Caldwell, S.H., Perticone, F., Gatta, A., Angelico, M., Farcomeni, A., Masotti, M., Napoleone, L., Vestri, A., Raparelli, V. and Basili, S. (2016) Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry. Internal and Emergency Medi-cine, 11, 1059-1066. [Google Scholar] [CrossRef] [PubMed]
[16] Yoshimatsu, R., Yamagami, T., Tanaka, O., et al. (2012) De-velopment of Thrombus in a Systemic Vein after Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices. Korean Journal of Radiology, 13, 324-331. [Google Scholar] [CrossRef] [PubMed]
[17] DeLeve, L.D., Valla, D.-C. and Garcia-Tsao, G. (2009) Vascular Disorders of the Liver. Hepatology, 49, 1729-1764. [Google Scholar] [CrossRef] [PubMed]
[18] Barbui, T., Finazzi, G. and Falanga, A. (2013) Myeloproliferative Neo-plasms and Thrombosis. Blood, 122, 2176-2184. [Google Scholar] [CrossRef] [PubMed]
[19] Falanga, A. and Marchetti, M. (2012) Thrombotic Disease in the Myeloproliferative Neoplasms. Hematology—American Society of Hematology Education Program, 2012, 571-581. [Google Scholar] [CrossRef] 
[20] Arellano-Rodrigo, E., Alvarez-Larrán, A., Re-verter, J.C., Villamor, N., Colomer, D. and Cervantes, F. (2006) Increased Platelet and Leukocyte Activation as Con-tributing Mechanisms for Thrombosis in Essential Thrombocythemia and Correlation with the JAK2 Mutational Status. Haematologica, 91, 169-175.
[21] Robertson, B., Urquhart, C., Ford, I., et al. (2007) Platelet and Coagulation Activa-tion Markers in Myeloproliferative Diseases: Relationships with JAK2 V6I7 F Status, Clonality, and Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis, 5, 1679-1685. [Google Scholar] [CrossRef] [PubMed]
[22] Saugel, B., Lee, M., Feichtinger, S., Hapfelmeier, A., Schmid, R.M. and Siveke, J.T. (2015) Thrombophilic Factor Analysis in Cirrhotic Patients with Portal Vein Thrombosis. The Journal of Thrombosis and Thrombolysis, 40, 54-60. [Google Scholar] [CrossRef] [PubMed]
[23] Amitrano, L., Brancaccio, V., Guardascione, M.A., Margaglione, M., Sacco, M., Martino, R., De Nucci, C., Mosca, S., Iannaccone, L., Ames, P.R., Romano, L. and Balzano, A. (2002) Portal Vein Thrombosis after Variceal Endoscopic Sclerotherapy in Cirrhotic Patients: Role of Genetic Thrombophilia. Endoscopy, 34, 535-538. [Google Scholar] [CrossRef] [PubMed]
[24] Erkan, O., Bozdayi, A.M., Disibeyaz, S., Oguz, D., Ozcan, M., Bahar, K., Karayalcin, S., Ozden, A., Bozkaya, H., Yurdaydin, C. and Uzunalimoglu, O. (2005) Thrombophilic Gene Mutations in Cirrhotic Patients with Portal Vein Thrombosis. European Journal of Gastroenterology & Hepatology, 17, 339-343. [Google Scholar] [CrossRef] [PubMed]
[25] Tripodi, A., Primignani, M., Chantarangkul, V., et al. (2009) An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma from Patients with Cirrhosis. Gastroenterology, 137, 2105-2111. [Google Scholar] [CrossRef] [PubMed]
[26] Gatt, A., Riddell, A., Calvaruso, V., Tuddenham, E.G., Makris, M. and Burroughs, A.K. (2010) Enhanced Thrombin Generation in Patients with Cirrhosis-Induced Coagulopathy. Journal of Thrombosis and Haemostasis, 8, 1994-2000. [Google Scholar] [CrossRef] [PubMed]
[27] Hugenholtz, G.C., Macrae, F., Adelmeijer, J., et al. (2016) Procoagulant Changes in Fibrin Clot Structure in Patients with Cirrhosis Are Associated with Oxidative Modifications of Fibrinogen. Journal of Thrombosis and Haemostasis, 14, 1054-1066. [Google Scholar] [CrossRef] [PubMed]
[28] Ambrosino, P., Tarantino, L., Di Minno, G., et al. (2017) The Risk of Ve-nous Thromboembolism in Patients with Cirrhosis. A Systematic Review and Meta-Analysis. Thrombosis and Haemo-stasis, 117, 139-148. [Google Scholar] [CrossRef] 
[29] Lancellotti, S., Basso, M., Veca, V., Sacco, M., Riccardi, L., Pompili, M. and De Cristofaro, R. (2016) Presence of Portal Vein Thrombosis in Liver Cirrhosis Is Strongly Associated with Low Levels of ADAMTS-13: A Pilot Study. Internal and Emergency Medicine, 11, 959-967. [Google Scholar] [CrossRef] [PubMed]
[30] Miku?a, T., Koz?owska, J., Stańczak, W., Sapu?a, M., Ró?yk, A. and Wiercińska-Drapa?o, A. (2018) Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis. Gastroen-terology Research and Practice, 2018, Article ID: 3287491. [Google Scholar] [CrossRef] [PubMed]
[31] Carnevale, R., Raparelli, V., Nocella, C., Bartimoccia, S., Novo, M., Severino, A., De Falco, E., Cammisotto, V., Pasquale, C., Crescioli, C., Scavalli, A.S., Riggio, O., Basili, S. and Violi, F. (2017) Gut-Derived Endotoxin Stimulates Factor VIII Secretion from Endothelial Cells. Implications for Hypercoagulability in Cirrhosis. Journal of Hepatology, 67, 950-956. [Google Scholar] [CrossRef] [PubMed]
[32] Violi, F., Ferro, D., Basili, S., Lionetti, R., Rossi, E., Merli, M., Riggio, O., Bezzi, M. and Capocaccia, L. (1997) Ongoing Prothrombotic State in the Portal Circulation of Cirrhotic Patients. Thrombosis and Haemostasis, 77, 44-47. [Google Scholar] [CrossRef] 
[33] Wosiewicz, P., ?orniak, M., Hartleb, M., Barański, K., Hartleb, M., Onyszczuk, M., Pilch-Kowalczyk, J. and Kyrcz-Krzemień, S. (2016) Portal Vein Thrombosis in Cirrhosis Is Not Asso-ciated with Intestinal Barrier Disruption or Increased Platelet Aggregability. Clinics and Research in Hepatology and Gastroenterology, 40, 722-729. [Google Scholar] [CrossRef] [PubMed]
[34] Amitrano, L., Guardascione, M.A., Brancaccio, V., Margaglione, M., Manguso, F., Iannaccone, L., Grandone, E. and Balzano, A. (2004) Risk Factors and Clinical Presentation of Portal Vein Thrombosis in Patients with Liver Cirrhosis. Journal of Hepatology, 40, 736-741. [Google Scholar] [CrossRef] [PubMed]
[35] Bagheri Lankarani, K., Homayon, K., Motevalli, D., Heidari, S.T., Alavian, S.M. and Malek-Hosseini, S.A. (2015) Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran. Hepatitis Monthly, 15, e26407. [Google Scholar] [CrossRef] [PubMed]
[36] Qi, X., Han, G., Ye, C., Zhang, Y., Dai, J., Peng, Y., Deng, H., Li, J., Hou, F., Ning, Z., Zhao, J., Zhang, X., Wang, R. and Guo, X. (2016) Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients. Medical Science Monitor, 22, 2528-2550. [Google Scholar] [CrossRef] 
[37] Politoske, D., Ralls, P. and Korula, J. (1996) Portal Vein Thrombosis Following Endoscopic Variceal Sclerotherapy. Prospective Controlled Comparison in Patients with Cirrhosis. Digestive Diseases and Sciences, 41, 185-190. [Google Scholar] [CrossRef] 

为你推荐